Trexquant Investment LP Kodiak Sciences Inc. Transaction History

Trexquant Investment LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$4.3 - $9.48 $96,694 - $213,176	22,487 Added 59.99%	59,970 $413,000
Q1 2023 May 15, 2023	SELL	$4.81 - $8.88 $219,480 - $405,194	-45,630 Reduced 54.9%	37,483 $232,000
Q4 2022 Feb 13, 2023	BUY	$6.52 - $8.05 $177,819 - $219,547	27,273 Added 48.84%	83,113 $595,000
Q3 2022 Nov 14, 2022	BUY	$7.57 - $12.5 $60,052 - $99,162	7,933 Added 16.56%	55,840 $432,000
Q2 2022 Aug 11, 2022	SELL	$5.04 - $9.48 $484,938 - $912,146	-96,218 Reduced 66.76%	47,907 $366,000
Q1 2022 May 13, 2022	BUY	$7.09 - $89.45 $1 Million - $12.7 Million	141,466 Added 5320.27%	144,125 $1.11 Million
Q4 2021 Feb 14, 2022	BUY	$80.85 - $128.49 $214,980 - $341,654	2,659 New	2,659 $225,000
Q2 2021 Aug 12, 2021	SELL	$77.2 - $126.54 $162,120 - $265,734	-2,100 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$110.45 - $164.47 $231,945 - $345,387	2,100 New	2,100 $238,000
Q2 2020 Aug 07, 2020	SELL	$42.74 - $66.25 $679,822 - $1.05 Million	-15,906 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$38.18 - $73.95 $251,606 - $487,330	6,590 Added 70.74%	15,906 $759,000
Q4 2019 Feb 12, 2020	BUY	$13.9 - $76.65 $129,492 - $714,071	9,316 New	9,316 $670,000

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $455M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.